Not sure I agree with these comments re: CR.... What makes you think a CR will be needed? IMU have ample cash in the kitty to fund trials for the foreseeable future and have hinted previously that they will likely look towards a licensing deal / JV in order to take the drugs to market..
If a good deal were struck, which included some form of upfront payment, what reasons would there be to pursue another CR and further dilute the shares on issue?
It's possible that another CR may occur, however this is completely speculative.... IMO - it's more likely that events will unfold in a manner in line with how management have previously hinted....ie. A partnership (JV) arrangement with big Pharma.
No rush in my mind - happy to hang on for the ride.
Whats IMU likely to be worth ?, page-34
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
-0.004(7.55%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.3¢ | 4.9¢ | $1.061M | 21.17M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 52 | 6583733 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 1287081 | 5 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |